Oct 5, 2026 · 3 min listen · Last updated October 5, 2026
From storyflo. This is your daily audio brief. Chloe, October 5th. The morning read — ten things in health worth the eight minutes. Let's get into it. First, from David Lebovitz Newsletter. Kathmandu. A friend’s 70th birthday celebration brought the author to Kathmandu, a city that’s always intrigued them.
Listen · storyflo · health and longevity
Daily Health & Wellness Brief · October 5th
0:00-3:16
Pick your daily storyteller
Subscribe to match with Theo, Jessica, Chloe, Mason, Brock — your voice, every brief.
Audio pre-rendered by Storyflo · cached + delivered from the edge
Kathmandu
A friend’s 70th birthday celebration brought the author to Kathmandu, a city that’s always intrigued them. This trip was spontaneous, and while they wish they had studied Nepalese cuisine beforehand, they believe food is the best way to understand a culture. Upon arrival, they were warned about the chaotic traffic, which made walking feel a bit like navigating a pinball machine, but they found the people to be kind and welcoming.
At their first meal, the author tried dhido, a buckwheat dumpling served with ghee. The experience was a bit challenging, as the waiter suggested eating it without chewing, which felt risky. While dhido wasn’t a favorite, locals appreciated their adventurous spirit in trying it.
#410 ‒ The biology of pregnancy: physiologic adaptation, gestational diabetes, preeclampsia, childbirth, and long-term maternal health | Kathryn Gray, M.D., Ph.D.
In a recent discussion, Dr. Kathryn Gray highlights how pregnancy acts as a significant stress test for a woman's body. It’s fascinating how the body adapts; for instance, plasma volume increases dramatically, which can strain the cardiovascular system. This shift also leads to higher insulin resistance, setting the stage for conditions like gestational diabetes.
Dr. Gray also touches on preeclampsia, a serious condition that can arise during pregnancy, emphasizing the need for careful monitoring. The conversation doesn’t stop at childbirth; it extends to long-term maternal health, suggesting that the physiological changes during pregnancy can have lasting effects. Overall, it’s a rich exploration of how pregnancy impacts women’s health both during and after this transformative period.
Easing constipation: A 20-minute walk can get your gut moving almost immediately
A recent study shows that a simple 20-minute walk can quickly get your gut moving. Researchers observed that just a couple of minutes after walking, bowel sounds became more pronounced and frequent, indicating that your intestines are working harder. This effect, while short-lived, highlights how even light exercise can be beneficial for relieving constipation.
So, if you're feeling a bit backed up, consider taking a brisk walk. It’s a straightforward way to potentially ease discomfort, and it doesn’t take much time at all. Just remember, this boost is temporary, but it might be a helpful tool in your routine.
The “glue” holding your cells together has a surprising second job
Researchers have found that E-cadherin, a protein traditionally known for keeping cells stuck together, has another important role. It helps epithelial cells, which line surfaces in the body, to engulf and digest nearby dead cells. This discovery came from studies using live zebrafish and mouse embryos.
What’s interesting is that while these cells reshape their lower surfaces to take in debris, their upper surfaces stay intact. This means they can maintain protective barriers even while cleaning up. It’s a neat example of how cells can multitask, keeping our tissues healthy while still doing their job of staying connected.
CSL to pay $355M upfront to co-develop Alentis’ kidney and liver drug
CSL, the Australian pharmaceutical company, has made a significant move by agreeing to pay $355 million upfront to Alentis Therapeutics for their anti-fibrosis drug aimed at treating kidney and liver conditions. This deal, announced recently, includes potential future payments that could total up to $1.2 billion, depending on the drug's development and sales milestones.
The collaboration focuses on addressing fibrosis, a condition where excessive connective tissue builds up in organs, leading to serious health issues. This partnership reflects CSL's ongoing commitment to expanding its portfolio in the field of rare diseases and chronic conditions.
While the upfront payment is substantial, the additional payments hinge on the drug's success in clinical trials and market performance. This strategic investment highlights the growing interest in therapies that target fibrosis, which has been a challenging area in medicine. Overall, this partnership could pave the way for advancements in treatment options for patients suffering from these conditions.
Send this story to anyone — or drop the embed into a blog post, Substack, Notion page. Every play sends rev-share back to storyflo · health and longevity.